| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001087913A3 Method for treating retinal degeneration with purinergic receptor agonists |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
| 05/30/2002 | WO2001046194A3 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
| 05/30/2002 | WO2001043759A3 Use of 11cby popypeptides and polynuceotides |
| 05/30/2002 | WO2001042282A9 Depsipeptide and congeners thereof for use as immunosuppressants |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | WO2001016300A3 Method of identifying inhibitors of cdc25 |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000013684A3 Pharmaceutical composition and method for treatment of inflammation |
| 05/30/2002 | US20020065416 Anti-inflammatory agents |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065327 Pharmaceutically active compounds and methods of use thereof |
| 05/30/2002 | US20020065322 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 05/30/2002 | US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc. |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 05/30/2002 | US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents |
| 05/30/2002 | US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 05/30/2002 | US20020065270 For use in therapy of inflammatory diseases such as, for example, rheumatoid arthritis |
| 05/30/2002 | US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065256 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064571 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis. |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | CA2430190A1 Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | CA2429579A1 Truncated cd200 |
| 05/30/2002 | CA2429570A1 Pyrimidine derivatives |
| 05/30/2002 | CA2429467A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2429313A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | CA2429309A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | CA2427284A1 Antiinflammation agents |
| 05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 05/29/2002 | EP1209158A1 Substituted beta-carbolines |
| 05/29/2002 | EP1209157A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 05/29/2002 | EP1208849A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing process |
| 05/29/2002 | EP1208847A2 Pharmaceutical compositions for treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin A and 40-O(2-hydroxyethyl)-rapamycin |
| 05/29/2002 | EP1208844A1 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
| 05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
| 05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 05/29/2002 | EP1208191A1 13 human colon and colon cancer associated proteins |
| 05/29/2002 | EP1208104A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1207898A2 Treatment of conjunctivitis |
| 05/29/2002 | EP1207897A2 Pharmaceutical compositions containing tripeptides |
| 05/29/2002 | EP1207882A1 Acyclic and cyclic amine derivatives |
| 05/29/2002 | EP1207877A1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP1207872A1 Ibuprofen-containing softgels |
| 05/29/2002 | EP1207868A1 Pharmaceutical tramadol salts |
| 05/29/2002 | EP1207867A1 Oral pharmaceutical forms of administration with a delayed action |
| 05/29/2002 | EP1207866A1 Delayed-action form of administration containing tramadol saccharinate |
| 05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
| 05/29/2002 | EP1207862A2 Arthritis treatment |
| 05/29/2002 | EP1207860A1 Controlled release pellet formulation |
| 05/29/2002 | EP1207858A1 Oral dosage forms |
| 05/29/2002 | EP1207856A2 Coformulation methods and their products |
| 05/29/2002 | EP1207855A1 Pharmaceutical composition comprising nabumetone |
| 05/29/2002 | EP1207852A1 Controlled release oral dosage suitable for oral administration |
| 05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 05/29/2002 | EP1061812A4 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 05/29/2002 | EP0799023B1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations |
| 05/29/2002 | DE10059020A1 Parenteral applizierbare Darreichungsformen Dosage forms can be administered parenterally |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351591A 抗炎吲哚衍生物 Indomethacin derivative |
| 05/29/2002 | CN1351590A Compounds |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1351498A Pyrrolotriazines inhibitors of kinases |